Genelux Corp

GNLXNASDAQ · USD
2.45USD0.00 (-0.81%)
122

Genelux Corp (GNLX) Covered Calls

As of September 29, 2026, GNLX has 2 covered call opportunities in the coming three months. Return ranges from 10.9 to 16.9% until expiration. Annualized return ranges from 19.6 to 55.2%. The nearest expiration is January 15, 2027. Maximum potential profit is $42.

Read more

Running GNLX covered calls helps you generate consistent income from Genelux Corp's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Genelux Corp involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best GNLX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if GNLX stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling GNLX covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Genelux Corp covered call is worth writing.

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1 to treat hematologic and solid cancer. The company was incorporated in 2001 and is headquartered in Westlake Village, California.

Income-focused investors, long-term GNLX holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling GNLX covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Genelux Corp covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile34.13% Neutral
  • Market cap (M$)111
  • 52 weeks high-71.31%
  • 52 weeks low6.99%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$18.83
    668.57% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-04
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.87
  • EPS growth next 5 years44.13%

As of September 29, 2026

2027-01-151122.500.810.401.2042.0016.9455.19-16.13+0.66530.80
2027-04-162032.500.810.254.9027.0010.8919.58-10.08+1.0004.65

As of September 29, 2026

Sell covered calls with the data behind you

Find the best GNLX covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial